Q32 Bio Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

QTTB

organization

SIC: 2834

SEC Insider

$204.4M

473 transactions

Summary

Q32 Bio Inc. (QTTB) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $82.0MSales: $109.9M65 insiders

Date	Insider	Type	Value
2026-05-28	Joint reporting: ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC	Buy	$10.0M
2026-05-28	Xu Diyong	Buy	$10.0M
2026-05-28	Joint reporting: ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC	Buy	$5.0M
2026-05-28	Xu Diyong	Buy	$5.0M
2026-01-15	Lundberg Sven Ante	A	$56K
2026-01-15	GRAYZEL DAVID S.	A	$45K
2026-02-25	Morrison Jodie Pope(CEO)	Sell	$45K
2026-02-25	Kalowski Lee(CFO and President)	Sell	$18K
2026-02-25	Violette Shelia M.(Chief Scientific Officer)	Sell	$13K
2026-06-12	Lundberg Sven Ante	A	$0
2026-06-12	Xu Diyong	A	$0
2026-06-12	Thistle Mary	A	$0
2026-06-12	GRAYZEL DAVID S.	A	$0
2026-06-12	TZIANABOS ARTHUR	A	$0
2026-06-12	Manke Isaac	A	$0
2026-06-12	Iwicki Mark T	A	$0
2026-06-12	LAPORTE KATHLEEN	A	$0
2026-02-24	Kalowski Lee(CFO and President)	A	$0
2026-02-24	Morrison Jodie Pope(CEO)	A	$0
2026-02-24	Violette Shelia M.(Chief Scientific Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Q32 Bio Inc. — Contributions, Lobbying & Contracts | Poliscope